Respiratory Hypersensitivity clinical trials
The registry lists 44 studies for Respiratory Hypersensitivity across more than 10 countries. 4 are recruiting or about to start. 3 of them are mainly about Respiratory Hypersensitivity (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06. Counting its 9 narrower conditions too, such as Asthma: 5,989 studies, 726 open.
Get an email when these change. Save the Respiratory Hypersensitivity studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
AstraZeneca (4) · University of Saskatchewan (3) · Bispebjerg Hospital (2) · Novartis Pharmaceuticals (2) · Columbia University (2) · AO GENERIUM (2) · Altair Therapeutics, Inc. (1) · Sanofi (1)
What is being tested here
Drugs under test in Respiratory Hypersensitivity studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Tilrekimig | 1 | 0 | 1 |
| Astaxanthine | 1 | 0 | 1 |
| Tezepelumab | 0 | 0 | 3 |
| Fluticasone | 0 | 0 | 3 |
| Budesonide | 0 | 0 | 2 |
| Fevipiprant | 0 | 2 | 2 |
| Montelukast | 0 | 0 | 2 |
| Salmeterol Xinafoate | 0 | 0 | 2 |
| Ciclesonide | 0 | 2 | 2 |
| Penehyclidine | 0 | 0 | 1 |
Drug classes tested here Corticosteroids 7 · Bronchodilators 3
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
Who these studies take
Of the 4 Respiratory Hypersensitivity studies recruiting now, 3 (75%) set no upper age limit and 1 (25%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (75%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 4 (100%) | 4 (100%) |
| 30 | 4 (100%) | 4 (100%) |
| 40 | 4 (100%) | 4 (100%) |
| 50 | 4 (100%) | 4 (100%) |
| 65 | 4 (100%) | 4 (100%) |
| 75 | 4 (100%) | 4 (100%) |
| 85 | 3 (75%) | 3 (75%) |
Across all 44 studies, recruiting or not: 64% stop at 75 or younger and 55% at 65; 20% take children; 0% are for women only and 0% for men only; 25% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 44 of 44. search them.
- A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe AsthmaRecruitingNCT06977581Phase 215 countries
- BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled AsthmaRecruitingNCT05341726Not applicable1 country
- Can Astaxanthin Help Manage Asthma in POlluted Areas?RecruitingNCT07507682Not applicable1 country
- The Effect of Anti-IL17 on Airway Hyperresponsiveness and ResistanceRecruitingNCT062246341 country
- Inhaling Penehyclidine to Prevent Perioperative Respiratory Adverse Events in Children at Risk Undergoing Sevoflurane AnesthesiaCompletedNCT06624696Phase 41 country
- A Clinical Trial for Evaluation of Efficacy, Safety and Immunogenicity of GNR-127 (Recombinant ABP Antigen Protein Which Carries a Birch Pollen Allergen [BET V 1] and an Apple Allergen [MAL D 1]) in Patients With Birch Pollen Allergic Rhinitis.CompletedNCT07155499Phase 1/21 country
- A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With AsthmaCompletedNCT06644924Phase 21 country
- Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild AsthmaCompletedNCT06563102Phase 41 country
- A Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Briquilimab in Participants With Allergic AsthmaTerminatedNCT06592768Phase 11 country
- Individualizing Treatment for Asthma in Primary CareCompletedNCT06272370Phase 41 country
- Indoor Air Quality for Black Adults With Uncontrolled AsthmaCompletedNCT056853811 country
- A Study of Genolair in Two Dosage Forms (Solution and Lyophilisate) and Xolair® in Healthy VolunteersCompletedNCT06494345Phase 11 country
- Tezepelumab and Methacholine Airway Hyperresponsiveness in Participants With Mild Allergic AsthmaStatus unknownNCT05740748Phase 21 country
- The RECONSTRUCT Study - Reconstructing Disease Mechanisms in AsthmaCompletedNCT03034005Phase 41 country
- Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)CompletedNCT03688074Phase 25 countries
- Systemic Corticosteroids Avoidance Study in Severe Asthma PatientsTerminatedNCT03629249Phase 321 countries
- Study of Efficacy of Fevipiprant in Patients With Nasal Polyposis and AsthmaCompletedNCT03681093Phase 39 countries
- Asthma Data Innovation Demonstration ProjectCompletedNCT02162576Not applicable1 country
- Effects of Anti-TSLP in Patients With AsthmaCompletedNCT02698501Phase 21 country
- Asthma and Allergy Screening AA2000 (Cross Sectional)CompletedNCT04727112
- Determining Baseline Respiratory Duty Cycles in Subjects With and Without Airway HyperresponsivenessCompletedNCT04001465Not applicable1 country
- Ai Chi Method for Children With AsthmaStatus unknownNCT03392129Not applicable1 country
- Effect of Vilanterol on Methacholine Challenge ResultsCompletedNCT03315000Phase 41 country
- Breathing Training for AsthmaCompletedNCT00975273Not applicable1 country
- Beta Blocker Therapy in Mild to Moderate AsthmaticsCompletedNCT01544634Phase 21 country
- Imaging Study of the Lungs During an Allergic Asthma AttackCompletedNCT01547286Not applicable1 country
- Change of Airway Hyperresponsiveness to Mannitol and Methacholine in Patients With AsthmaCompletedNCT01725360Phase 41 country
- Investigation of Novel Procedure for Methacholine Challenge TestingCompletedNCT02965482Not applicable1 country
- Airway Hyper-responsiveness Study In Asthma Using Salmeterol/Fluticasone Propionate Combination ProductCompletedNCT00291382Phase 410 countries
- Effect of Inhaled Ciclesonide in Adult Patients With Asthma (BY9010/M1-125)CompletedNCT00546520Phase 31 country
- Asthma Intervention Research (AIR) TrialCompletedNCT00214526Not applicable
- Anti-histamines and Methacholine Challenges.CompletedNCT01985789Phase 41 country
- Small Airways Disease in Asymptomatic and Symptomatic Subjects With Airway Hyperresponsiveness (AHR)CompletedNCT015494831 country
- Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial AsthmaCompletedNCT00263640Phase 31 country
- Functional Implications of TNFCompletedNCT007291311 country
- The Effect of Aspirin Desensitization on Patients With Aspirin-exacerbated Respiratory DiseasesCompletedNCT01867281Phase 41 country
- Sensitivity and Specificity of Aridol Challenge for a Diagnosis of Asthma by a Specialist PulmonologistTerminatedNCT004911531 country
- A Mechanistic Study to Evaluate the Efficacy of Montelukast on Airway Function in AsthmaStatus unknownNCT01841164Not applicable1 country
- Effect of Dietary Supplements With Fish Oil on Mannitol-induced Airway Sensitivity & Inflammation in Persons With AsthmaCompletedNCT00526357Phase 21 country
- Study Evaluating the Effects of AIR645 on Allergen-Induced Airway Responses in Subjects With Mild Atopic AsthmaCompletedNCT00941577Phase 21 country
- Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent AsthmaCompletedNCT00254956Phase 31 country
- Airway Dysfunction and Remodelling in Athletes Following Swimming Training in Chlorinated PoolsStatus unknownNCT006864521 country
- Effect of Salmeterol on Brain-Derived Neurotrophic Factor (BDNF) Concentrations in AsthmaCompletedNCT00736801Not applicable1 country
- Bronchospasm Associated With High Nitric OxideCompletedNCT006665101 country